Overview

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Europe B.V.
Treatments:
Tacrolimus